2024 Q3 Form 10-K Financial Statement

#000095017024104782 Filed on September 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.798M $7.583M $2.997M
YoY Change -20.54% 11.94% -50.08%
% of Gross Profit
Research & Development $0.00 $2.462M $0.00
YoY Change -100.0% 32.37% -100.0%
% of Gross Profit
Depreciation & Amortization $4.972M $5.050M $48.00K
YoY Change 9281.13% 5389.13% 2.78%
% of Gross Profit
Operating Expenses $12.91M $15.06M $4.205M
YoY Change 67.39% 73.34% -49.2%
Operating Profit -$12.91M -$4.205M
YoY Change 67.39% -49.2%
Interest Expense $2.155M -$1.065M $822.0K
YoY Change 20.59% -32.51% -63.25%
% of Operating Profit
Other Income/Expense, Net $52.00K -$1.000K -$21.70M
YoY Change -103.14% -108.33% 1081.27%
Pretax Income -$12.86M -$16.12M -$25.91M
YoY Change 37.24% 57.26% 156.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.86M -$16.12M -$25.91M
YoY Change 37.24% 57.26% 156.1%
Net Earnings / Revenue
Basic Earnings Per Share -$0.20 -$0.44
Diluted Earnings Per Share -$0.20 -$0.26 -$0.44
COMMON SHARES
Basic Shares Outstanding 68.83M 63.29M 63.29M
Diluted Shares Outstanding 65.47M 58.51M

Balance Sheet

Concept 2024 Q3 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.851M $4.896M $7.986M
YoY Change -41.92% -75.91% -77.92%
Cash & Equivalents $6.851M $4.896M $7.986M
Short-Term Investments
Other Short-Term Assets $1.258M $1.913M $2.012M
YoY Change -1.18% 5.81% 6.34%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.109M $6.809M $9.998M
YoY Change -37.95% -69.23% -73.73%
LONG-TERM ASSETS
Property, Plant & Equipment $68.62M $73.87M $3.000M
YoY Change 2141.85% 2317.28% -2.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $317.0K $317.0K $314.0K
YoY Change 0.96% 0.63% -71.25%
Total Long-Term Assets $77.67M $82.70M $86.97M
YoY Change -6.06% 4.99% 18.21%
TOTAL ASSETS
Total Short-Term Assets $8.109M $6.809M $9.998M
Total Long-Term Assets $77.67M $82.70M $86.97M
Total Assets $85.77M $89.50M $96.96M
YoY Change -10.41% -11.29% -13.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.481M $854.0K $1.973M
YoY Change -25.09% -42.76% -54.21%
Accrued Expenses $5.988M $8.812M $5.255M
YoY Change -16.9% 20.19% -26.22%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $42.00K $42.00K $41.00K
YoY Change 2.44% 5.0% 2.5%
Total Short-Term Liabilities $7.511M $9.708M $7.269M
YoY Change -18.57% 9.52% -36.64%
LONG-TERM LIABILITIES
Long-Term Debt $81.12M $71.74M $65.75M
YoY Change 27.43% 16.05% 6.34%
Other Long-Term Liabilities $3.738M $4.259M $957.0K
YoY Change 373.76% 433.71% 24.29%
Total Long-Term Liabilities $81.12M $71.74M $65.75M
YoY Change 27.43% 16.05% 6.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.511M $9.708M $7.269M
Total Long-Term Liabilities $81.12M $71.74M $65.75M
Total Liabilities $83.68M $78.80M $71.50M
YoY Change 64.16% 66.48% 47.51%
SHAREHOLDERS EQUITY
Retained Earnings -$212.9M -$200.0M -$183.9M
YoY Change 44.45% 44.94% 43.95%
Common Stock $689.0K $633.0K $633.0K
YoY Change 55.88% 43.54% 43.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.094M $10.71M $25.46M
YoY Change
Total Liabilities & Shareholders Equity $85.77M $89.50M $96.96M
YoY Change -10.41% -11.29% -13.14%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income -$12.86M -$16.12M -$25.91M
YoY Change 37.24% 57.26% 156.1%
Depreciation, Depletion And Amortization $4.972M $5.050M $48.00K
YoY Change 9281.13% 5389.13% 2.78%
Cash From Operating Activities -$6.375M -$7.235M -$4.865M
YoY Change -7.42% 10.14% -38.75%
INVESTING ACTIVITIES
Capital Expenditures $11.00K $1.309M $2.392M
YoY Change -78.43% -86.97% -82.82%
Acquisitions
YoY Change
Other Investing Activities $86.00K $0.00
YoY Change -100.0%
Cash From Investing Activities -$400.0K -$1.309M -$2.392M
YoY Change -75.48% -85.88% -82.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.730M 5.454M 13.20M
YoY Change -87400.0% -60700.0% 927.88%
NET CHANGE
Cash From Operating Activities -6.375M -7.235M -4.865M
Cash From Investing Activities -400.0K -1.309M -2.392M
Cash From Financing Activities 8.730M 5.454M 13.20M
Net Change In Cash 1.955M -3.090M 5.941M
YoY Change -122.93% -80.5% -128.87%
FREE CASH FLOW
Cash From Operating Activities -$6.375M -$7.235M -$4.865M
Capital Expenditures $11.00K $1.309M $2.392M
Free Cash Flow -$6.386M -$8.544M -$7.257M
YoY Change -7.94% -48.57% -66.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001888654
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
001-41279
CY2024 dei Entity Registrant Name
EntityRegistrantName
5E ADVANCED MATERIALS, INC.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3426517
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
9329 Mariposa Road
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Hesperia
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92344
CY2024 dei City Area Code
CityAreaCode
442
CY2024 dei Local Phone Number
LocalPhoneNumber
221-0225
CY2024 dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
CY2024 dei Trading Symbol
TradingSymbol
FEAM
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
54900000
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
68826797
CY2024 dei Auditor Firm
AuditorFirmId
238
CY2024 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2024 dei Auditor Location
AuditorLocation
Denver, Colorado
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4896000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20323000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1913000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1808000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
6809000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
22131000
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7616000
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7637000
CY2024Q2 feam Construction In Progress
ConstructionInProgress
608000
CY2023Q2 feam Construction In Progress
ConstructionInProgress
67553000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73872000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3056000
CY2024Q2 feam Reclamation Bond Deposit
ReclamationBondDeposit
311000
CY2023Q2 feam Reclamation Bond Deposit
ReclamationBondDeposit
309000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
282000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
207000
CY2024Q2 us-gaap Other Assets
OtherAssets
6000
CY2023Q2 us-gaap Other Assets
OtherAssets
6000
CY2024Q2 us-gaap Assets
Assets
89504000
CY2023Q2 us-gaap Assets
Assets
100899000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9567000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8728000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
141000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
136000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
9708000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8864000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
64831000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
37671000
CY2024Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3315000
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
149000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74000
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
795000
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
724000
CY2024Q2 us-gaap Liabilities
Liabilities
78798000
CY2023Q2 us-gaap Liabilities
Liabilities
47333000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
360000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63318000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44187000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
633000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
441000
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
210074000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
191113000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-200001000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137988000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10706000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53566000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89504000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
100899000
CY2024 feam Project Expenses
ProjectExpenses
6631000
CY2023 feam Project Expenses
ProjectExpenses
9988000
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24014000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25365000
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
262000
CY2024 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
908000
CY2024 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5170000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
184000
CY2024 us-gaap Operating Expenses
OperatingExpenses
35860000
CY2023 us-gaap Operating Expenses
OperatingExpenses
36707000
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-35860000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-36707000
CY2024 us-gaap Investment Income Interest
InvestmentIncomeInterest
252000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
1147000
CY2024 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7000
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
62000
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20953000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
749000
CY2023 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
11743000
CY2024 us-gaap Interest Expense
InterestExpense
6199000
CY2023 us-gaap Interest Expense
InterestExpense
6854000
CY2024 feam Other Non Operating Income Expense Excluding Other Income
OtherNonOperatingIncomeExpenseExcludingOtherIncome
-9000
CY2023 feam Other Non Operating Income Expense Excluding Other Income
OtherNonOperatingIncomeExpenseExcludingOtherIncome
-15000
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26153000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6083000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62013000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30624000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-62013000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.18
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.7
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.7
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52523000
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52523000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43842000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43842000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-62013000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5170000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
184000
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
3490000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
4953000
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-20953000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2024 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
749000
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
11743000
CY2024 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
908000
CY2024 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
71000
CY2023 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
37000
CY2024 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3481000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4907000
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
159000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
164000
CY2024 feam Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
-2000
CY2023 feam Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
0
CY2024 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
105000
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
302000
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2673000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
821000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26872000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30695000
CY2024 feam Payments For Construction In Progress
PaymentsForConstructionInProgress
7099000
CY2023 feam Payments For Construction In Progress
PaymentsForConstructionInProgress
39731000
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
352000
CY2024 feam Payments For Reclamation Bonds
PaymentsForReclamationBonds
0
CY2023 feam Payments For Reclamation Bonds
PaymentsForReclamationBonds
-776000
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7187000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39307000
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15794000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2024 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
6000000
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
60000000
CY2024 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3122000
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4160000
CY2024 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
40000
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
38000
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3466000
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18632000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59268000
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15427000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10734000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20323000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31057000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4896000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20323000
CY2024 us-gaap Interest Paid Net
InterestPaidNet
23000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
7000
CY2024 feam Construction In Progress Transferred To Properties Plant And Equipment
ConstructionInProgressTransferredToPropertiesPlantAndEquipment
75877000
CY2023 feam Construction In Progress Transferred To Properties Plant And Equipment
ConstructionInProgressTransferredToPropertiesPlantAndEquipment
0
CY2024 feam Accounts Payable And Accrued Liabilities Change Related To Construction In Progress
AccountsPayableAndAccruedLiabilitiesChangeRelatedToConstructionInProgress
1833000
CY2023 feam Accounts Payable And Accrued Liabilities Change Related To Construction In Progress
AccountsPayableAndAccruedLiabilitiesChangeRelatedToConstructionInProgress
2197000
CY2024 feam Recognition Of Operating Lease Liabilities And Right Of Use Assets
RecognitionOfOperatingLeaseLiabilitiesAndRightOfUseAssets
234000
CY2023 feam Recognition Of Operating Lease Liabilities And Right Of Use Assets
RecognitionOfOperatingLeaseLiabilitiesAndRightOfUseAssets
0
CY2024 feam Increase Decrease In Asset Retirement Costs
IncreaseDecreaseInAssetRetirementCosts
0
CY2023 feam Increase Decrease In Asset Retirement Costs
IncreaseDecreaseInAssetRetirementCosts
198000
CY2024 feam Increase In Net Long Term Debt Resulting From Modification
IncreaseInNetLongTermDebtResultingFromModification
20953000
CY2023 feam Increase In Net Long Term Debt Resulting From Modification
IncreaseInNetLongTermDebtResultingFromModification
0
CY2024 feam Interest Paid Through Issuance Of Additional Convertible Notes
InterestPaidThroughIssuanceOfAdditionalConvertibleNotes
3961000
CY2023 feam Interest Paid Through Issuance Of Additional Convertible Notes
InterestPaidThroughIssuanceOfAdditionalConvertibleNotes
1710000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
62662000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3466000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-44000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4953000
CY2023 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
13153000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-30624000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
53566000
CY2024 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15794000
CY2024 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-131000
CY2024 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3490000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-62013000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10706000
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentrations of Risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company maintains cash deposits at several major banks, which at times may exceed amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation. Management monitors the financial health of the banks and believes the Company is not exposed to any significant credit risk, and the Company has not experienced any such losses.</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s operations are predominately focused on the Project, which results in the Company being dependent upon a single mining operation in a single geographic region in the western United States in California. The geographic concentration of the Company’s operations may disproportionately expose it to disruptions if the region experiences severe weather, transportation capacity constraints, constraints on the availability of required equipment, facilities, personnel or services, significant governmental regulation or natural disasters.</span></p>
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Items that are subject to such estimates and assumptions include, but are not limited to, estimated useful lives and valuation of properties, plant and equipment, mineral rights and properties, deferred tax assets, estimation of future costs, useful life, and discount rates used to calculate the asset retirement obligations (“ARO”), assumptions used to value the embedded conversion option of the Convertible Notes, and fair value of stock-based compensation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></p>
CY2024Q2 feam Reclamation Bond Deposit Current
ReclamationBondDepositCurrent
311000
CY2023Q2 feam Reclamation Bond Deposit Current
ReclamationBondDepositCurrent
309000
CY2024 feam Percentage Of Tax Benefit To Be Realized For Recognition In The Income Statement
PercentageOfTaxBenefitToBeRealizedForRecognitionInTheIncomeStatement
0.50
CY2024 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications have been made to prior years’ reported amounts in order to conform to the current year presentation. These reclassifications did not impact our previously reported net income (loss), stockholders’ equity or cash flows.</span></p>
CY2023Q1 us-gaap Mineral Properties Accumulated Impairment
MineralPropertiesAccumulatedImpairment
908000
CY2024Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7616000
CY2023Q2 us-gaap Mineral Properties Net
MineralPropertiesNet
7637000
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
608000
CY2023Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
67553000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79339000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3374000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5467000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
318000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73872000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3056000
CY2024 us-gaap Depreciation
Depreciation
5200000
CY2023 us-gaap Depreciation
Depreciation
184000
CY2023Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
724000
CY2024 us-gaap Asset Retirement Obligation Liabilities Incurred
AssetRetirementObligationLiabilitiesIncurred
0
CY2024 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0
CY2024 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
71000
CY2024Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
795000
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
854000
CY2023Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1492000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
603000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1350000
CY2024Q2 feam Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
3309000
CY2023Q2 feam Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
3386000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2263000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1072000
CY2024Q2 feam Accrued Interest Current
AccruedInterestCurrent
2496000
CY2023Q2 feam Accrued Interest Current
AccruedInterestCurrent
1388000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
40000
CY2024Q2 feam Accounts Payable And Accrued Liabilities Including Current Portion Of Long Term Debt
AccountsPayableAndAccruedLiabilitiesIncludingCurrentPortionOfLongTermDebt
9567000
CY2023Q2 feam Accounts Payable And Accrued Liabilities Including Current Portion Of Long Term Debt
AccountsPayableAndAccruedLiabilitiesIncludingCurrentPortionOfLongTermDebt
8728000
CY2024Q2 feam Capital Expenditure Included In Trade Accounts Payable
CapitalExpenditureIncludedInTradeAccountsPayable
235000
CY2023Q2 feam Capital Expenditure Included In Trade Accounts Payable
CapitalExpenditureIncludedInTradeAccountsPayable
699000000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
71779000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
61858000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
42000
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
40000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
71737000
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
61818000
CY2024Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4035000
CY2023Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20691000
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2871000
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3456000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
64831000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
37671000
CY2024 feam Convertible Note Interest
ConvertibleNoteInterest
5068000
CY2023 feam Convertible Note Interest
ConvertibleNoteInterest
3098000
CY2024 feam Vehicle Notes Payable Interest
VehicleNotesPayableInterest
5000
CY2023 feam Vehicle Notes Payable Interest
VehicleNotesPayableInterest
7000
CY2024 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3481000
CY2023 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4907000
CY2024 us-gaap Interest Expense Other
InterestExpenseOther
19000
CY2023 us-gaap Interest Expense Other
InterestExpenseOther
0
CY2024 feam Gross Interest Expense
GrossInterestExpense
8573000
CY2023 feam Gross Interest Expense
GrossInterestExpense
8012000
CY2024 feam Amount Capitalized To Construction In Progress
AmountCapitalizedToConstructionInProgress
2374000
CY2023 feam Amount Capitalized To Construction In Progress
AmountCapitalizedToConstructionInProgress
1158000
CY2024 us-gaap Interest Expense
InterestExpense
6199000
CY2023 us-gaap Interest Expense
InterestExpense
6854000
CY2024 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.179
CY2023 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.253
CY2022Q2 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
0
CY2023 feam Convertible Note Derivative Additions
ConvertibleNoteDerivativeAdditions
24896000
CY2023 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
11743000
CY2023 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
13153000
CY2023Q2 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
0
CY2024 feam Convertible Note Derivative Additions
ConvertibleNoteDerivativeAdditions
4064000
CY2024 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
749000
CY2024Q2 feam Convertible Note Derivative Liability
ConvertibleNoteDerivativeLiability
3315000
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15800000
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4187000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.91
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4874000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.67
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
575000
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.64
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
800000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.67
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
835000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.15
CY2024 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriod
-761000
CY2024 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriodWeightedAverageExercisePrice
14.47
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriod
-652000
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Options Expired Or Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredOrForfeitedInPeriodWeightedAverageExercisePrice
17.42
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4001000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.33
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4187000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.91
CY2024 feam Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
3660000
CY2024 feam Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
9.8
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsVestedInPeriod
3349000
CY2023 feam Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
9.82
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
341000
CY2024Q2 feam Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
4.23
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
838000
CY2023Q2 feam Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice
15.23
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
838000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.42
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1507000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.05
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
575000
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.44
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
800000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.11
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
490000
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
9.24
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1177000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
5.88
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
582000
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
6.12
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
292000
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.26
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
341000
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.79
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
838000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.42
CY2024 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6200000
CY2024 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
8573000
CY2023 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
8012000
CY2024 feam Derivative Gain Loss On Convertible Notes Derivatives
DerivativeGainLossOnConvertibleNotesDerivatives
749000
CY2023 feam Derivative Gain Loss On Convertible Notes Derivatives
DerivativeGainLossOnConvertibleNotesDerivatives
11743000
CY2024 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
46615000
CY2023 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
3506000
CY2024 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4601000
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4724000
CY2024 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
183000
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
206000
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
4200000
CY2023Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
5500000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-62013000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30624000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
0
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62013000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30624000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62013000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-30624000
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
13023000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6431000
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2691000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1755000
CY2024 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
-12000
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
1769000
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-423000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-185000
CY2024 feam Income Tax Reconciliation Nondeductible Expense Interest On Convertible Note
IncomeTaxReconciliationNondeductibleExpenseInterestOnConvertibleNote
-438000
CY2023 feam Income Tax Reconciliation Nondeductible Expense Interest On Convertible Note
IncomeTaxReconciliationNondeductibleExpenseInterestOnConvertibleNote
-649000
CY2024 feam Income Tax Reconciliation Impact Of Change In Functional Currency
IncomeTaxReconciliationImpactOfChangeInFunctionalCurrency
0
CY2023 feam Income Tax Reconciliation Impact Of Change In Functional Currency
IncomeTaxReconciliationImpactOfChangeInFunctionalCurrency
-743000
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-103000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-256000
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2024 feam Income Tax Reconciliation Disallowed Exploration Costs
IncomeTaxReconciliationDisallowedExplorationCosts
0
CY2023 feam Income Tax Reconciliation Disallowed Exploration Costs
IncomeTaxReconciliationDisallowedExplorationCosts
0
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-14762000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4584000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
25924000
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
18781000
CY2024Q2 feam Deferred Tax Assets Amortization Of Exploration Expenditures
DeferredTaxAssetsAmortizationOfExplorationExpenditures
8948000
CY2023Q2 feam Deferred Tax Assets Amortization Of Exploration Expenditures
DeferredTaxAssetsAmortizationOfExplorationExpenditures
8437000
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3168000
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2796000
CY2024Q2 feam Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
226000
CY2023Q2 feam Deferred Tax Assets Depreciation
DeferredTaxAssetsDepreciation
0
CY2024Q2 feam Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
737000
CY2023Q2 feam Deferred Tax Assets Interest Limitation
DeferredTaxAssetsInterestLimitation
2000
CY2024Q2 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
885000
CY2023Q2 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
914000
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
738000
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40802000
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30754000
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39403000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24791000
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1399000
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
5963000
CY2024Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
1077000
CY2023Q2 us-gaap Deferred Tax Liabilities Deferred Expense Deferred Financing Costs
DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts
5773000
CY2024Q2 feam Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
0
CY2023Q2 feam Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
33000
CY2024Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
322000
CY2023Q2 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
157000
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2024 feam Operating Loss Carryforwards Expiration Period
OperatingLossCarryforwardsExpirationPeriod
P2037Y
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39400000
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24800000
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14612000
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1120000
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q2 ecd Insider Trd Policies Proc Adopted Flag
InsiderTrdPoliciesProcAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 feam Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q2 feam Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-104782-index-headers.html Edgar Link pending
0000950170-24-104782-index.html Edgar Link pending
0000950170-24-104782.txt Edgar Link pending
0000950170-24-104782-xbrl.zip Edgar Link pending
feam-20240630.htm Edgar Link pending
feam-20240630.xsd Edgar Link pending
feam-ex10_26.htm Edgar Link pending
feam-ex10_28.htm Edgar Link pending
feam-ex21_1.htm Edgar Link pending
feam-ex23_1.htm Edgar Link pending
feam-ex23_2.htm Edgar Link pending
feam-ex23_3.htm Edgar Link pending
feam-ex23_4.htm Edgar Link pending
feam-ex23_5.htm Edgar Link pending
feam-ex23_6.htm Edgar Link pending
feam-ex23_7.htm Edgar Link pending
feam-ex31_1.htm Edgar Link pending
feam-ex31_2.htm Edgar Link pending
feam-ex32_1.htm Edgar Link pending
feam-ex32_2.htm Edgar Link pending
feam-ex4_1.htm Edgar Link pending
feam-ex97_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img212522565_0.jpg Edgar Link pending
img212522565_1.jpg Edgar Link pending
img212522565_2.jpg Edgar Link pending
img212522565_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
feam-20240630_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending